Factors Associated With Patients Not Receiving Oral Anticancer Drugs
暂无分享,去创建一个
Shing M. Lee | E. Elkin | D. Hershman | M. Accordino | M. Lichtenstein | Sahil D. Doshi | R. Raghunathan | Melissa P. Beauchemin | J. D. Wright | Cynthia Law
[1] Laura A. Levit,et al. Call to Action for Improving Oral Anticancer Agent Adherence. , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Pengxiang Li,et al. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Shields,et al. Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature , 2016, Patient preference and adherence.
[4] A. Neugut,et al. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL) , 2012, Breast Cancer Research and Treatment.
[5] J. Griggs,et al. Patterns and correlates of adjuvant breast cancer endocrine therapy use. , 2011, Journal of Clinical Oncology.
[6] V. Quinn,et al. When to intervene to increase use of adjuvant hormone therapy among women with hormone-sensitive breast cancer. , 2011, Journal of Clinical Oncology.
[7] L. Schwartzberg,et al. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. , 2011, Journal of oncology practice.
[8] F. Camacho,et al. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Vanchieri. When will the U.S. flinch at cancer drug prices? , 2005, Journal of the National Cancer Institute.
[10] Aliza K Fink,et al. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] E. Winer,et al. Adherence to therapy with oral antineoplastic agents. , 2002, Journal of the National Cancer Institute.